These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34138906)

  • 1. Duration of SARS-CoV-2 shedding: A population-based, Canadian study.
    Phillips SP; Wei X; Kwong JC; Gubbay J; Schwartz KL; Majury A; Groome PA
    PLoS One; 2021; 16(6):e0252217. PubMed ID: 34138906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and potential factors for recurrence of positive SARS-CoV-2 RNA in convalescent patients: a retrospective cohort study.
    Ao Z; Li Y; Wei J; Jiang J; Wang X; Zhang P; Liu Y; Yu H; Zhu L; Wang X; Hu Q; Duan J; Hu W; Zhang X; Wu G; Guo S
    Clin Exp Med; 2021 Aug; 21(3):361-367. PubMed ID: 33543353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent SARS-CoV-2 RNA Shedding Without Evidence of Infectiousness: A Cohort Study of Individuals With COVID-19.
    Owusu D; Pomeroy MA; Lewis NM; Wadhwa A; Yousaf AR; Whitaker B; Dietrich E; Hall AJ; Chu V; Thornburg N; Christensen K; Kiphibane T; Willardson S; Westergaard R; Dasu T; Pray IW; Bhattacharyya S; Dunn A; Tate JE; Kirking HL; Matanock A;
    J Infect Dis; 2021 Oct; 224(8):1362-1371. PubMed ID: 33649773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three COVID-19 cases with a long-term viral shedding period in Tunisia.
    Bennasrallah C; Bannour R; Jlassi O; Kacem M; Fredj MB; Abroug H; Zemni I; Garrach B; Bahri R; Charfeddine N; Triki S; Sriha AB
    Pan Afr Med J; 2020; 35(Suppl 2):117. PubMed ID: 33282072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of Viral Clearance and Antibody Production Across Age Groups in Children with Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Bahar B; Jacquot C; Mo YD; DeBiasi RL; Campos J; Delaney M
    J Pediatr; 2020 Dec; 227():31-37.e1. PubMed ID: 32891640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An approach to lifting self-isolation for health care workers with prolonged shedding of SARS-CoV-2 RNA.
    Laferl H; Kelani H; Seitz T; Holzer B; Zimpernik I; Steinrigl A; Schmoll F; Wenisch C; Allerberger F
    Infection; 2021 Feb; 49(1):95-101. PubMed ID: 33025521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients.
    Buetti N; Trimboli P; Mazzuchelli T; Lo Priore E; Balmelli C; Trkola A; Conti M; Martinetti G; Elzi L; Ceschi A; Consonni V; Ogna A; Forni-Ogna V; Bernasconi E
    Endocrine; 2020 Dec; 70(3):454-460. PubMed ID: 32870469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding viral shedding of severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Review of current literature.
    Fontana LM; Villamagna AH; Sikka MK; McGregor JC
    Infect Control Hosp Epidemiol; 2021 Jun; 42(6):659-668. PubMed ID: 33077007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of SARS-CoV-2 RNA in the nasopharyngeal, blood, urine, and stool samples of patients with COVID-19: a hospital-based longitudinal study.
    Joukar F; Yaghubi Kalurazi T; Khoshsorour M; Taramian S; Mahfoozi L; Balou HA; Jafarinezhad A; Pourkazemi A; Hesni E; Asgharnezhad M; Shenagari M; Jahanzad I; Naghipour M; Maroufizadeh S; Mansour-Ghanaei F
    Virol J; 2021 Jul; 18(1):134. PubMed ID: 34210325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment and Consulting Doctor Later: A Retrospective Cohort Study.
    He XL; Zhou YY; Fu W; Xue YE; Liang MY; Yang BH; Ma WL; Zhou Q; Chen L; Zhang JC; Wang XR
    Curr Med Sci; 2021 Dec; 41(6):1096-1104. PubMed ID: 34515914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent viral RNA shedding after COVID-19 symptom resolution in older convalescent plasma donors.
    Hartman WR; Hess AS; Connor JP
    Transfusion; 2020 Oct; 60(10):2189-2191. PubMed ID: 32533556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inference of Active Viral Replication in Cases with Sustained Positive Reverse Transcription-PCR Results for SARS-CoV-2.
    Rodríguez-Grande C; Adán-Jiménez J; Catalán P; Alcalá L; Estévez A; Muñoz P; Pérez-Lago L; García de Viedma D
    J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33239378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of age on duration of viral RNA shedding in patients with COVID-19.
    Zhou C; Zhang T; Ren H; Sun S; Yu X; Sheng J; Shi Y; Zhao H
    Aging (Albany NY); 2020 Nov; 12(22):22399-22404. PubMed ID: 33223506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of potential COVID-19 recurrence in patients with late repeat positive SARS-CoV-2 testing.
    Peltan ID; Beesley SJ; Webb BJ; Lopansri BK; Sinclair W; Jacobs JR; Brown SM
    PLoS One; 2021; 16(5):e0251214. PubMed ID: 33945583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for SARS-CoV-2 re-positivity in COVID-19 patients after discharge.
    Hong LX; Liu L; Lin A; Yan WH
    Int Immunopharmacol; 2021 Jun; 95():107579. PubMed ID: 33756229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with prolonged viral shedding and impact of lopinavir/ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection.
    Yan D; Liu XY; Zhu YN; Huang L; Dan BT; Zhang GJ; Gao YH
    Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32430428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trajectory of Viral RNA Load Among Persons With Incident SARS-CoV-2 G614 Infection (Wuhan Strain) in Association With COVID-19 Symptom Onset and Severity.
    Stankiewicz Karita HC; Dong TQ; Johnston C; Neuzil KM; Paasche-Orlow MK; Kissinger PJ; Bershteyn A; Thorpe LE; Deming M; Kottkamp A; Laufer M; Landovitz RJ; Luk A; Hoffman R; Roychoudhury P; Magaret CA; Greninger AL; Huang ML; Jerome KR; Wener M; Celum C; Chu HY; Baeten JM; Wald A; Barnabas RV; Brown ER
    JAMA Netw Open; 2022 Jan; 5(1):e2142796. PubMed ID: 35006245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity in testing, diagnosis and outcome in SARS-CoV-2 infection across outbreak settings in the Greater Toronto Area, Canada: an observational study.
    Wang L; Ma H; Yiu KCY; Calzavara A; Landsman D; Luong L; Chan AK; Kustra R; Kwong JC; Boily MC; Hwang S; Straus S; Baral SD; Mishra S
    CMAJ Open; 2020; 8(4):E627-E636. PubMed ID: 33037070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical course and treatment efficacy of COVID-19 near Hubei Province, China: A multicentre, retrospective study.
    Zeng QL; Li GM; Ji F; Ma SH; Zhang GF; Xu JH; Lin WB; Xu GH; Zhang GQ; Li GT; Cui GL; Liu N; Zeng FJ; Ai ZG; Xu GF; Liu N; Liang J; Zhang MM; Li C; Zhang ZH; Wang ZS; Li Z; Yu ZJ
    Transbound Emerg Dis; 2020 Nov; 67(6):2971-2982. PubMed ID: 32531138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual and social determinants of SARS-CoV-2 testing and positivity in Ontario, Canada: a population-wide study.
    Sundaram ME; Calzavara A; Mishra S; Kustra R; Chan AK; Hamilton MA; Djebli M; Rosella LC; Watson T; Chen H; Chen B; Baral SD; Kwong JC
    CMAJ; 2021 May; 193(20):E723-E734. PubMed ID: 33906966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.